Skip to main content
Premium Trial:

Request an Annual Quote

Number Crunch The Axe Falls, Again and Again

Premium

In the last year, more than 1,300 people have been laid off in the genomics sector as the market slides and staff reductions seem one of the only answers. The companies and their employee losses since last September:

Aclara: 50
Bruker Daltonics: 45
Celera Genomics: 132
Cellomics: 50
Genaissance Pharmaceuticals: 20%
GeneMachines: 20
Genomics Solution: 43
Genset: closed San Diego R&D facility
Incyte: 400
InforMax: 73
Invitrogen: 175, and closed Huntsville, Ala.,
manufacturing center
Large Scale Biology: 58
Lynx Therapeutics: 44
Medichem: 25%
Paradigm: 50
Third Wave Technologies: 75
Valentis: 45
Variagenics: 40
Xanthon: 10
Numbers are approximate.

 

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.